Caplin Point Laboratories Announces 35th AGM on Sep 25, 2026, to Discuss FY26 Results & Dividend
Caplin Point Laboratories will hold its 35th AGM on September 25, 2026, via VC/OAVM. The meeting will approve FY26 financial statements and declare a final dividend of ₹4 (200%), totaling ₹8 (400%) for the year. Dr. Sridhar Ganesan's re-appointment as MD for 2 years and Mr. D Muralidharan's appointment as Whole-Time Director are also on the agenda.
The AGM involves crucial decisions regarding financial statements, dividend declaration, and key management appointments/re-appointments, which are material to the company's governance and future operations.
The announcement is a routine notice for the Annual General Meeting and does not contain any significant positive or negative financial news or strategic developments.
Caplin Point Laboratories Limited has announced its 35th Annual General Meeting (AGM) for the Financial Year 2025-26, scheduled to be held on Friday, September 25, 2026, at 10:00 AM IST. The meeting will be conducted through Video Conferencing / Other Audio-Visual Means (VC/OAVM) in compliance with MCA and SEBI circulars.
The AGM agenda includes the adoption of Audited Standalone and Consolidated Financial Statements for the financial year ended March 31, 2026, along with the Board and Auditors' reports. Shareholders will also consider the declaration of a final dividend of ₹4/- (200%) per equity share, which, along with the ratified interim dividend of ₹4/- (200%), aggregates to ₹8/- (400%) for the year ended March 31, 2026.
Key appointments and re-appointments are also on the agenda. Dr. Sridhar Ganesan, who retires by rotation, is proposed for re-appointment as a Director and also for re-appointment as the Managing Director for a period of 2 years from August 25, 2026, to August 24, 2028, with an annual salary of ₹55,20,000, along with other allowances and benefits. Mr. C. C. Paarthipan's continuation as Chairman and Non-Executive, Non-Independent Director, despite attaining the age of 75, will be considered. Additionally, Mr. D Muralidharan is proposed for appointment as a Whole-Time Director for two years from August 12, 2026, to August 11, 2028, with an annual salary of ₹62,37,600, and will continue as CFO without additional monetary compensation.
The cut-off date for e-voting is Friday, September 18, 2026. E-voting will commence on Tuesday, September 22, 2026, at 9:00 AM IST and conclude on Thursday, September 24, 2026, at 5:00 PM IST via the NSDL e-voting website.
A plain-language summary of a public exchange filing by Caplin Point Laboratories Limited. Read the original for the full detail.